INVIA, LLC, Ann Arbor, MI, USA.
Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA.
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):123-135. doi: 10.1007/s00259-023-06448-1. Epub 2023 Oct 3.
Although treatment of ischemia-causing epicardial stenoses may improve symptoms of ischemia, current evidence does not suggest that revascularization improves survival. Conventional myocardial ischemia imaging does not uniquely identify diffuse atherosclerosis, microvascular dysfunction, or nonobstructive epicardial stenoses. We sought to evaluate the prognostic value of integrated myocardial flow reserve (iMFR), a novel noninvasive approach to distinguish the perfusion impact of focal atherosclerosis from diffuse coronary disease.
This study analyzed a large single-center registry of consecutive patients clinically referred for rest-stress myocardial perfusion positron emission tomography. Cox proportional hazards modeling was used to assess the association of two previously reported and two novel perfusion measures with mortality risk: global stress myocardial blood flow (MBF); global myocardial flow reserve (MFR); and two metrics derived from iMFR analysis: the extents of focal and diffusely impaired perfusion.
In total, 6867 patients were included with a median follow-up of 3.4 years [1st-3rd quartiles, 1.9-5.0] and 1444 deaths (21%). Although all evaluated perfusion measures were independently associated with death, diffusely impaired perfusion extent (hazard ratio 2.65, 95%C.I. [2.37-2.97]) and global MFR (HR 2.29, 95%C.I. [2.08-2.52]) were consistently stronger predictors than stress MBF (HR 1.62, 95%C.I. [1.46-1.79]). Focally impaired perfusion extent (HR 1.09, 95%C.I. [1.03-1.16]) was only moderately related to mortality. Diffusely impaired perfusion extent remained a significant independent predictor of death when combined with global MFR (p < 0.0001), providing improved risk stratification (overall net reclassification improvement 0.246, 95%C.I. [0.183-0.310]).
The extent of diffusely impaired perfusion is a strong independent and additive marker of mortality risk beyond traditional risk factors, standard perfusion imaging, and global MFR, while focally impaired perfusion is only moderately related to mortality.
尽管治疗导致缺血的外膜狭窄可以改善缺血症状,但现有证据表明血运重建并不能提高生存率。传统的心肌缺血影像学并不能唯一识别弥漫性动脉粥样硬化、微血管功能障碍或非阻塞性外膜狭窄。我们试图评估整合心肌血流储备(iMFR)的预后价值,这是一种新的非侵入性方法,用于区分局灶性动脉粥样硬化和弥漫性冠状动脉疾病的灌注影响。
本研究分析了一项大型单中心连续患者静息-应激心肌灌注正电子发射断层扫描临床转诊登记研究。使用 Cox 比例风险模型评估两种先前报道和两种新的灌注指标与死亡率风险的相关性:整体应激心肌血流(MBF);整体心肌血流储备(MFR);以及从 iMFR 分析中得出的两个指标:局灶性和弥漫性灌注受损程度。
共纳入 6867 例患者,中位随访时间为 3.4 年[第 1-3 四分位数,1.9-5.0],1444 例死亡(21%)。尽管所有评估的灌注指标与死亡均独立相关,但弥漫性灌注受损程度(危险比 2.65,95%CI [2.37-2.97])和整体 MFR(HR 2.29,95%CI [2.08-2.52])始终是比应激 MBF(HR 1.62,95%CI [1.46-1.79])更强的预测指标。局灶性灌注受损程度(HR 1.09,95%CI [1.03-1.16])与死亡率仅中度相关。当与整体 MFR 结合时,弥漫性灌注受损程度仍然是死亡的独立预测指标(p<0.0001),提供了更好的风险分层(总体净重新分类改善 0.246,95%CI [0.183-0.310])。
弥漫性灌注受损程度是传统危险因素、标准灌注成像和整体 MFR 之外死亡率风险的强烈独立和附加标志物,而局灶性灌注受损程度与死亡率仅中度相关。